Загрузка...

Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration

1. Apremilast is a novel, orally available small molecule that specifically inhibits PDE4and thus modulates multiple pro- and anti-inflammatory mediators, and is currently under clinical development for the treatment of psoriasis and psoriatic arthritis.The pharmacokinetics and disposition of [(14)C...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hoffmann, Matthew, Kumar, Gondi, Schafer, Peter, Cedzik, Dorota, Capone, Lori, Kei-Fong, Lai, Gu, Zheming, Heller, Dennis, Feng, Hao, Surapaneni, Sekhar, Laskin, Oscar, Wu, Anfan
Формат: Artigo
Язык:Inglês
Опубликовано: Informa Healthcare 2011
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3231940/
https://ncbi.nlm.nih.gov/pubmed/21859393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00498254.2011.604745
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!